Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lucia Torracca HEART FAILURE & Co. Milano aprile 2010

Similar presentations


Presentation on theme: "Lucia Torracca HEART FAILURE & Co. Milano aprile 2010"— Presentation transcript:

1 Lucia Torracca HEART FAILURE & Co. Milano 9 - 10 aprile 2010
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 Lucia Torracca

2 Il bypass aorto-coronarico: più rischioso e meno efficace?
L. Torracca Direttore U.O. Cardiochirurgia A.O.U. Ospedali Riuniti “Umberto I- G. M. Lancisi- G. Salesi” Presidio Monospecialistico “G. M. Lancisi” Ancona

3 Preoperative risk profile (women versus men)
Older Diabetes/Obesity/Hypertension Smaller body surface area Lower hematocrit Congestive heart failure/NYHA class IV IV heparin/nitroglycerin Urgent/emergent operation Higher STS estimated mortality Single center consecutive 1743 pts Aldea Ann Thorac Surg 1999

4 Gender profiling in CABG
15,597 pts Cleveland Clinic Koch JTCVS 2003;126:2044

5 Operative mortality 344,913 pts from STS database 5

6 Operative mortality 6

7 Operative mortality 7

8 Operative mortality 8

9 Operative mortality 9

10 Operative risk factors
Aldea Ann Thorac Surg 1999 10

11 Operative risk factors Internal mammary artery use
FEMALE vs MALE 64% 78% O’Connor 1993 65% 76% Edwards 1998 67% 80% Humphries 2007 83% 89% Bukkapatnam 2010 11

12 Outcome 1113 pts followed for 6-8 weeks after CABG 12

13 QOL before and after CABG
Peric V. ICVTS 2010;10:232

14 QOL before and after CABG
Peric V. ICVTS 2010;10:232

15 Quality of life 15

16

17 Women may benefit of a more aggressive rehabilitation program

18 - 2 groups of patients 261 women and 261 men “computer-matched”
- All pts bilateral IMA graft - Hospital mortality 3,4% vs 3,8% (women vs men)

19

20

21

22 Gender and off-pump 22

23 Gender and off-pump 23

24 Female and leg wound complications
Paletta Ann Thorac Surg 2000;70:492 24

25 Endoscopic vein harvesting
Yun JCTS 2005;129:496

26 Increase the use of “at least” one or “better” two mammary arteries
Optimal management of blood glucose level ( mg/dl) Intraop management of anemia (nadir Ht>22 during CPB): reduce pump prime, ultrafiltration 26

27 Use of off-pump surgery ? Optimization of thyroxine treatment
Hormone replacement therapy??? 27

28 Thanks for the attention!


Download ppt "Lucia Torracca HEART FAILURE & Co. Milano aprile 2010"

Similar presentations


Ads by Google